Diagnos Laboratorium Utama PT Tbk (DGNS) — Cash Flow Reinvestment Rate
Diagnos Laboratorium Utama PT Tbk (DGNS) has a Cash Flow Reinvestment Rate of 1.74x as of June 2025, reinvesting Rp2.64 Billion (capex Rp2.64 Billion ) from operating cash flow of Rp1.52 Billion. Check Diagnos Laboratorium Utama PT Tbk (DGNS) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Diagnos Laboratorium Utama PT Tbk Cash Flow Reinvestment Rate (2018–2024)
Historical reinvestment intensity for Diagnos Laboratorium Utama PT Tbk across 6 annual periods. Explore Diagnos Laboratorium Utama PT Tbk cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Diagnos Laboratorium Utama PT Tbk (2018–2024)
Year-by-year capital reinvestment analysis for Diagnos Laboratorium Utama PT Tbk. For live market cap and broader valuation context, see DGNS company net worth.
| Year | Reinvestment Rate | Total Reinvested (IDR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.59x | Rp43.39 Billion | Rp27.30 Billion | Rp43.39 Billion | ▼ -45.3% |
| 2023 | 2.91x | Rp38.32 Billion | Rp13.18 Billion | Rp38.32 Billion | ▲ +130.2% |
| 2021 | 1.26x | Rp74.35 Billion | Rp58.87 Billion | Rp67.84 Billion | ▲ +167.7% |
| 2020 | 0.47x | Rp12.37 Billion | Rp26.23 Billion | Rp5.86 Billion | ▼ -43.2% |
| 2019 | 0.83x | Rp9.29 Billion | Rp11.20 Billion | Rp2.78 Billion | ▼ -32.1% |
| 2018 | 1.22x | Rp10.34 Billion | Rp8.47 Billion | Rp3.84 Billion | — |